Home > Insider Trading > Filing (0001437749-15-004008)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1386858	Hyperion Therapeutics Inc	HPTX	Pharmaceutical Preparations (2834)	611512713

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1554402	Frederick Bruce Scharschmidt	C/O Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA 94005	Svp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-02-27	24,996	$29.79	29,252	No	4	S	Indirect	By The Bruce Frederick Scharschimdt and Peggy Sue
Common Stock	Disposition	2015-02-27	4,804	$30.43	24,448	No	4	S	Indirect	Crawford Family Trust dated October 9, 2001

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By The Bruce Frederick Scharschimdt and Peggy Sue
No	4	S	Indirect	Crawford Family Trust dated October 9, 2001

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	97,471	Direct

Footnotes

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27-$30.26. The reporting person undertakes to provide Hyperion Therapeutics, Inc, any security holder of Hyperion Therapeutics, Inc or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in column 4 is weighted average price. These shares were sold in multiple transactions ranging from $30.26-$30.59, inclusive.